StockMacro
Company, fund or insider

Help

Menu

Ainos

$1.18 -63% in 6 monthsMarket cap $10.3M

AIMD on XNAS, Technology, Ainos, Inc., job postings

Measures activity, not value. Not investment advice.

Revenue jumped 479% to $654K while a delisting notice arrived and the net loss hit $13.4M.

  • BadDebt of $13.8M against $661K cash on the balance sheet

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Industry
Computer peripheral equipment, nec (Technology)
Employees
41
Website
ainos.com
Listed
Nasdaq, US
Last results
16 Nov 2026
Next results
expected around 29 Mar 2027 (an estimate: a year ago it reported on 30 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $643K, net loss $1.9M.
Quarter to 31 Dec 2021: revenue $26K, net income -$1.4MQuarter to 31 Dec 2021: revenue $26K, net income -$1.4MQuarter to 31 Mar 2022: revenue $87K, net income -$2.1MQuarter to 31 Mar 2022: revenue $87K, net income -$2.1MQuarter to 30 Jun 2022: revenue $637K, net income -$2.0MQuarter to 30 Jun 2022: revenue $637K, net income -$2.0MQuarter to 30 Sep 2022: revenue $1.8M, net income -$7.8MQuarter to 30 Sep 2022: revenue $1.8M, net income -$7.8MQuarter to 31 Dec 2022: revenue $1.0M, net income -$2.1MQuarter to 31 Dec 2022: revenue $1.0M, net income -$2.1MQuarter to 31 Mar 2023: revenue $49K, net income -$2.5MQuarter to 31 Mar 2023: revenue $49K, net income -$2.5MQuarter to 30 Jun 2023: revenue $29K, net income -$2.3MQuarter to 30 Jun 2023: revenue $29K, net income -$2.3MQuarter to 30 Sep 2023: revenue $24K, net income -$3.0MQuarter to 30 Sep 2023: revenue $24K, net income -$3.0MQuarter to 31 Dec 2023: revenue $20K, net income -$5.9MQuarter to 31 Dec 2023: revenue $20K, net income -$5.9MQuarter to 31 Mar 2024: revenue $21K, net income -$3.3MQuarter to 31 Mar 2024: revenue $21K, net income -$3.3MQuarter to 30 Jun 2024: revenue $0, net income -$3.2MQuarter to 30 Jun 2024: revenue $0, net income -$3.2MQuarter to 30 Sep 2024: revenue $0, net income -$3.7MQuarter to 30 Sep 2024: revenue $0, net income -$3.7MQuarter to 31 Dec 2024: revenue $0, net income -$4.7MQuarter to 31 Dec 2024: revenue $0, net income -$4.7MQuarter to 31 Mar 2025: revenue $106K, net income -$3.3MQuarter to 31 Mar 2025: revenue $106K, net income -$3.3MQuarter to 30 Jun 2025: revenue $5K, net income -$4.1MQuarter to 30 Jun 2025: revenue $5K, net income -$4.1MQuarter to 30 Sep 2025: revenue $2K, net income -$2.9MQuarter to 30 Sep 2025: revenue $2K, net income -$2.9MQuarter to 31 Dec 2025: revenue $11K, net income -$4.5MQuarter to 31 Dec 2025: revenue $11K, net income -$4.5MQuarter to 31 Mar 2026: revenue $161, net income -$2.5MQuarter to 31 Mar 2026: revenue $161, net income -$2.5MQuarter to 30 Jun 2026: revenue $152, net income -$4.6MQuarter to 30 Jun 2026: revenue $152, net income -$4.6MQuarter to 30 Sep 2026: revenue $643K, net income -$1.9MQuarter to 30 Sep 2026: revenue $643K, net income -$1.9M
31 Dec 2021RevenueNet incomeNet losstallest bar $7.8M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$643K-$1.9M
30 Jun 2026$152-$4.6M
31 Mar 2026$161-$2.5M
31 Dec 2025$11K-$4.5M
30 Sep 2025$2K-$2.9M
30 Jun 2025$5K-$4.1M
31 Mar 2025$106K-$3.3M
31 Dec 2024$0-$4.7M
30 Sep 2024$0-$3.7M
30 Jun 2024$0-$3.2M
31 Mar 2024$21K-$3.3M
31 Dec 2023$20K-$5.9M
30 Sep 2023$24K-$3.0M
30 Jun 2023$29K-$2.3M
31 Mar 2023$49K-$2.5M
31 Dec 2022$1.0M-$2.1M
30 Sep 2022$1.8M-$7.8M
30 Jun 2022$637K-$2.0M
31 Mar 2022$87K-$2.1M
31 Dec 2021$26K-$1.4M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $654K $113K
Revenue growthRevenue of the last 12 months compared with the 12 months before. +479% +8.0%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$13.4M -$15.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$2.07 -$2.93
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. 83.3% 82.7% 45.5%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – 2.5%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – 0.6%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -228% 3.0%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $661K $1.1M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $13.8M $11.0M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). $13.2M $9.9M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 8.0 0.08
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.23
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 26.2
P/SPrice to sales: market cap divided by revenue of the last 12 months. 13.6 2.7
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. 33.7 3.1
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 5.2 3.3

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
AinosAIMD (this company) $10.3Mloss13.6+479%–
VirtuixVTIX $12.8Mloss3.1-12%-626%
Wetouch TechnologyWETH $31.3M3.70.64+12%17.2%
Interlink ElectronicsLINK $33.2Mloss2.6+6.1%-7.7%
Transact TechnologiesTACT $46.7Mloss0.86+8.0%-1.6%
INVE TechnologiesINVE $52.3Mloss2.3+1.5%-50.3%

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

2.7%

205K shares held by 13F filers (30 Sep 2026) of 7.6M outstanding (16 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

0.5%

38K shares sold short (30 Oct 2026) of 7.6M outstanding (16 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

1.4

38K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-20%

47K shares sold short in the report before, 38K on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

40%

40% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 36%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

18

18 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

18×

18 articles in the last 7 days; its usual week has 1.

Price $1.18 on 20 Nov 2026, -38% over 12 months (12-month range $0.47 to $3.16)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders sold a net $469K in the last 12 months (the 12 months before: -$191K).
Revenue per quarter. Revenue $643K in the latest quarter, +29567% on a year earlier.
Capital spending per quarter. Capital spending $6K in the latest quarter.
Institutional holders (13F filers). 15 13F filers reported holding it in the latest 13F quarter, +25% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
20 Nov 20268-K and other filingsNasdaq notice: stockholders' equity below the minimum
10 Jul 20268-K and other filingsChanged its auditor
31 Jul 20258-K and other filingsChanged its auditor
28 Jan 2025Sharp changeShort interest spike: short interest spike, 634K vs usual 118K (2025-01-15); 17.3x the same period a year earlier
9 Aug 20248-K and other filingsDirector or officer change
9 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
19 Jul 20248-K and other filingsDelisting notice or listing transfer
8 Apr 20248-K and other filingsRegistered new securities for sale (S-1)
19 Mar 20248-K and other filingsDirector or officer change
15 Mar 20248-K and other filingsDirector or officer change
15 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Dec 20238-K and other filingsRegistered new securities for sale (S-1)
8 Dec 20238-K and other filingsRegistered new securities for sale (S-1)
24 Nov 20238-K and other filingsDirector or officer change
24 Nov 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Jul 20238-K and other filingsDelisting notice or listing transfer
18 May 20238-K and other filingsDirector or officer change
18 May 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
11 Apr 20238-K and other filingsChanged its auditor
1 Apr 20238-K and other filingsReport will be filed late
10 Jan 20238-K and other filingsDelisting notice or listing transfer
2 Aug 20228-K and other filingsRegistered new securities for sale (S-1)
27 Jul 20228-K and other filingsRegistered new securities for sale (S-1)
23 Jul 20228-K and other filingsRegistered new securities for sale (S-1)
8 Jul 20228-K and other filingsRegistered new securities for sale (S-1)
24 Jun 20228-K and other filingsDirector or officer change
16 Jun 20228-K and other filingsDirector or officer change
16 Jun 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
28 Apr 20228-K and other filingsRegistered new securities for sale (S-1)
4 Apr 20228-K and other filingsDelisting notice or listing transfer
4 Apr 20228-K and other filingsCompleted an acquisition or asset sale
17 Mar 20228-K and other filingsDirector or officer change
3 Feb 20228-K and other filingsCompleted an acquisition or asset sale
29 Dec 20218-K and other filingsDirector or officer change
29 Dec 2021Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
22 Dec 2021Sharp changeClustered insider buying: clustered insider buying (4 independent filers, 4 filing(s) in 30 days, value_usd total 1.5M)
Insider net buying (open market)
Month from 1 Dec 2021: $1.5M published
Month from 1 Nov 2022: $4K published
Month from 1 Apr 2023: -$252K published
Month from 1 Jun 2025: -$24K published
Month from 1 Jul 2025: -$39K published
Month from 1 Aug 2025: -$86K published
Month from 1 Oct 2025: -$42K published
Month from 1 Jan 2026: -$102K published
Month from 1 May 2026: -$379K published
Month from 1 Jun 2026: $12K published
Revenue per quarter
Quarter ended 31 Dec 2021: $26K, +3743% on a year earlier; public on 22 Mar 2022
Quarter ended 31 Mar 2022: $87K, +4011% on a year earlier; public on 17 May 2022
Quarter ended 30 Jun 2022: $637K, +214% on a year earlier; public on 16 Aug 2022
Quarter ended 30 Sep 2022: $1.8M, +384% on a year earlier; public on 15 Nov 2022
Quarter ended 31 Dec 2022: $1.0M, +3832% on a year earlier; public on 4 Apr 2023
Quarter ended 31 Mar 2023: $49K, -44% on a year earlier; public on 13 May 2023
Quarter ended 30 Jun 2023: $29K, -96% on a year earlier; public on 12 Aug 2023
Quarter ended 30 Sep 2023: $24K, -99% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $20K, -98% on a year earlier; public on 9 Mar 2024
Quarter ended 31 Mar 2024: $21K, -58% on a year earlier; public on 14 May 2024
Quarter ended 30 Jun 2024: $0, -100% on a year earlier; public on 6 Aug 2024
Quarter ended 30 Sep 2024: $0, -100% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $0, -100% on a year earlier; public on 8 Mar 2025
Quarter ended 31 Mar 2025: $106K, +412% on a year earlier; public on 15 May 2025
Quarter ended 30 Jun 2025: $5K; public on 14 Aug 2025
Quarter ended 30 Sep 2025: $2K; public on 14 Nov 2025
Quarter ended 31 Dec 2025: $11K; public on 31 Mar 2026
Quarter ended 31 Mar 2026: $161, -100% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $152, -97% on a year earlier; public on 4 Aug 2026
Quarter ended 30 Sep 2026: $643K, +29567% on a year earlier; public on 17 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $102K; public on 22 Mar 2022
Quarter ended 31 Mar 2022: $136K; public on 13 May 2023
Quarter ended 31 Mar 2023: $72K, -47% on a year earlier; public on 13 May 2023
Quarter ended 30 Sep 2023: $37K; public on 10 Nov 2023
Quarter ended 31 Mar 2024: $4K, -94% on a year earlier; public on 14 May 2024
Quarter ended 30 Jun 2024: $6K; public on 6 Aug 2024
Quarter ended 30 Sep 2024: $10K, -72% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $908; public on 8 Mar 2025
Quarter ended 31 Mar 2025: $34K, +660% on a year earlier; public on 15 May 2025
Quarter ended 30 Sep 2025: $10K, -0.1% on a year earlier; public on 14 Nov 2025
Quarter ended 31 Mar 2026: $9K, -75% on a year earlier; public on 14 May 2026
Quarter ended 30 Jun 2026: $6K; public on 4 Aug 2026
Institutional holders (13F filers)
30 Sep 2022 report: 7; public on 14 Nov 2022
31 Dec 2022 report: 6; public on 14 Feb 2023
31 Mar 2023 report: 8; public on 15 May 2023
30 Jun 2023 report: 5; public on 14 Aug 2023
30 Sep 2023 report: 15; public on 14 Nov 2023
31 Dec 2023 report: 5; public on 14 Feb 2024
31 Mar 2024 report: 9; public on 15 May 2024
30 Jun 2024 report: 9; public on 14 Aug 2024
30 Sep 2024 report: 8; public on 14 Nov 2024
31 Dec 2024 report: 8; public on 14 Feb 2025
31 Mar 2025 report: 12; public on 15 May 2025
30 Jun 2025 report: 7; public on 14 Aug 2025
30 Sep 2025 report: 12; public on 14 Nov 2025
31 Dec 2025 report: 14; public on 17 Feb 2026
31 Mar 2026 report: 12; public on 15 May 2026
30 Jun 2026 report: 14; public on 14 Aug 2026
30 Sep 2026 report: 15; public on 16 Nov 2026

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is gross profit, quarter at $536K (30 Sep 2026), 229274% below its normal quarter of -$234; higher than 98% of its own history.
  • Insider net buying (open market): Insiders sold a net $469K in the last 12 months (the 12 months before: -$191K).
  • Revenue per quarter: Revenue $643K in the latest quarter, +29567% on a year earlier.
  • Capital spending per quarter: Capital spending $6K in the latest quarter.

Latest records

The names and amounts behind the totals, newest first

No trades in the last 90 days; the latest was filed 9 Jun 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
9 Jun 2026yao-chung chiangDirectorBuy3,500$2.05$7KForm 4
5 Jun 2026yao-chung chiangDirectorBuy2,000$2.13$4KForm 4
1 Jun 2026yao-chung chiangDirectorBuy250$2.30$575Form 4
29 May 2026yao-chung chiangDirectorBuy2,000$2.00$4KForm 4
27 May 2026ting-chuan leeDirectorSell109,988$1.90$209KForm 4
27 May 2026Chun-Jung TsaiDirectorSell28,800$1.86$54KForm 4
27 May 2026Taiwan Carbon Nano Technology Corp10% ownerSell41,000$2.36$97KForm 4
26 May 2026ting-chuan leeDirectorSell18,302$1.57$29KForm 4

15 institutions reported shares at the end of Q3 2026, 3% of the shares outstanding; 3 opened a position, 2 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Geode Capital Management, LLC44K0.58%$56K-194-0.4%
Vanguard Capital Management LLC34K0.45%$43K+18K+112%
Principal Securities, Inc.32K0.42%$40KNew+32K
Envestnet Asset Management Inc32K0.42%$40KNew+32K
Keystone Financial Group25K0.33%$32K-300-1.2%
Mariner, LLC16K0.21%$20KNo change
Vanguard Fiduciary Trust Co14K0.19%$18KNo change
BlackRock, Inc.3,0650.04%$4KNo change
Citigroup Inc1,7020.02%$2K+1,525+862%
Tower Research Capital LLC (TRC)1,6830.02%$2K-1,474-47%

Company events

All 82 company events

In 12 months: 2 major agreements, 1 auditor change, 1 delisting notice. Results releases and routine reports are left out.

FiledWhat happenedSource
20 Nov 2026Nasdaq notice: stockholders' equity below the minimum8-K
17 Nov 2026Agreed to sell 5,000 AI NOSE units to ASE Technology Holding Co., Ltd. for US$9,000,000; deposit of US$4,500,000 due within 60 days8-K
28 Sep 2026Signed a major agreement8-K
10 Jul 2026Changed its auditor8-K
17 Oct 2025Signed a major agreement8-K
31 Jul 2025Changed its auditor8-K
14 Mar 2025Signed a major agreement8-K
10 Mar 2025Signed a major agreement8-K

No lobbying spend reported yet. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
1 Jan 2014EndedHance Scarboroughfor Amarillo Biosciences IncNot statedFiling
13 Aug 2007NewHance Scarboroughfor Amarillo Biosciences IncHealth issuesFiling

The 5 newest of 70 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 20 Nov 2026Filings record

    Nasdaq notice: stockholders' equity below the minimum

  2. 10 Jul 2026Filings record

    Changed its auditor

  3. 10 Jun 2026Insiders record

    chiang yao-chung (director) bought 3,500 shares of AIMD ($7,175) (dated 9 Jun 2026)

  4. 6 Jun 2026Insiders record

    chiang yao-chung (director) bought 2,000 shares of AIMD ($4,260) (dated 5 Jun 2026)

  5. 2 Jun 2026Insiders record

    chiang yao-chung (director) bought 250 shares of AIMD ($575) (dated 1 Jun 2026)

  6. 30 May 2026Insiders record

    chiang yao-chung (director) bought 2,000 shares of AIMD ($4,000) (dated 29 May 2026)

  7. 21 May 2026Insiders record

    chiang yao-chung (director) bought 2,700 shares of AIMD ($4,521) (dated 20 May 2026)

  8. 8 May 2026Insiders record

    chiang yao-chung (director) bought 129 shares of AIMD ($219) (dated 7 May 2026)

  9. 2 May 2026Insiders record

    chiang yao-chung (director) bought 300 shares of AIMD ($511) (dated 1 May 2026)

  10. 31 Jul 2025Filings record

    Changed its auditor

  11. 26 Jun 2025Insiders record

    ASE Test, Inc. (ten percent owner) bought 29,476 shares of AIMD [not an open-market trade] (dated 25 Jun 2025)

  12. 28 Jan 2025Short interest and volume change

    had 634K shares sold short in the 15 Jan 2025 report, 17× the same report last year.

    Same report last year: 37K; its normal report is 118K.

    See the evidence
    This period
    634K (the 15 Jan 2025 report)
    Normal report (median of 24 earlier)
    118K
    Typical spread (median absolute deviation)
    64K
    How far from its usual level
    +5.5
    Same report last year
    37K
    History used
    1,328 days
    2024-01-12: 37K2024-01-31: 22K2024-02-15: 22K2024-02-29: 7,5512024-03-15: 91K2024-03-28: 79K2024-04-15: 73K2024-04-30: 56K2024-05-15: 98K2024-05-31: 90K2024-06-14: 52K2024-06-28: 395K2024-07-15: 289K2024-07-31: 375K2024-08-15: 396K2024-08-30: 170K2024-09-13: 123K2024-09-30: 382K2024-10-15: 239K2024-10-31: 143K2024-11-15: 113K2024-11-29: 162K2024-12-13: 256K2024-12-31: 177K2025-01-15: 634K
    the 15 Jan 2025 report24 earlier reportsnormal: 118K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 9 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  14. 9 Aug 2024Filings record

    Director or officer change

  15. 19 Jul 2024Filings record

    Delisting notice or listing transfer

  16. 8 Apr 2024Filings record

    Registered new securities for sale (S-1)

  17. 19 Mar 2024Filings record

    Director or officer change

  18. 15 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  19. 15 Mar 2024Filings record

    Director or officer change

  20. 15 Dec 2023Filings record

    Registered new securities for sale (S-1)

  21. 8 Dec 2023Filings record

    Registered new securities for sale (S-1)

  22. 24 Nov 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  23. 24 Nov 2023Filings record

    Director or officer change

  24. 6 Jul 2023Filings record

    Delisting notice or listing transfer

  25. 18 May 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  26. 18 May 2023Filings record

    Director or officer change

  27. 27 Apr 2023Insiders record

    lee ting-chuan (director) bought 61,157 shares of AIMD ($48,314) (dated 26 Apr 2023)

  28. 11 Apr 2023Filings record

    Changed its auditor

  29. 1 Apr 2023Filings record

    Report will be filed late (dated 31 Mar 2023)

  30. 10 Jan 2023Filings record

    Delisting notice or listing transfer

  31. 15 Nov 2022Insiders record

    tsai chung-jung (director) bought 8,932 shares of AIMD ($4,466) (dated 14 Nov 2022)

  32. 2 Aug 2022Filings record

    Registered new securities for sale (S-1)

  33. 27 Jul 2022Filings record

    Registered new securities for sale (S-1)

  34. 23 Jul 2022Filings record

    Registered new securities for sale (S-1) (dated 22 Jul 2022)

  35. 8 Jul 2022Filings record

    Registered new securities for sale (S-1)

  36. 24 Jun 2022Filings record

    Director or officer change

  37. 16 Jun 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 16 Jun 2022Filings record

    Director or officer change

  39. 28 Apr 2022Filings record

    Registered new securities for sale (S-1)

  40. 4 Apr 2022Filings record

    Delisting notice or listing transfer

Showing the newest 40 of 132 entries; narrow the window or the kind of data to see older ones.

Not listed: 122 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001014763
Ticker
AIMD
Domain
ainos.com
Hq location
TX|HOUSTON|77056 (1 unverified)
Lobbying client
amarillo biosciences
Name
Ainos, Inc., AMARILLO BIOSCIENCES INC, EX-21.1, ex21-1.htm and 3 more
  • Federal lobbying disclosures (LDA)2 records, 56 data points31 Dec 2006 to 31 Mar 2014
  • SEC Form 13F institutional holdings153 data points30 Sep 2022 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)161 records30 Mar 2016 to 20 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)1001 data points31 Dec 2009 to 16 Nov 2026
  • SEC Form 4 insider transactions257 records, 960 data points26 Feb 2016 to 9 Jun 2026
  • FINRA short interest (twice monthly)389 data points28 May 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2130 data points9 Aug 2022 to 20 Nov 2026